Belgium remains a global player in vaccine development
Belgium is strengthening its position as an international hub for biotechnology. Hanne Callewaert, co-founder of the innovative company AstriVax, even calls our country the 'Silicon Valley of vaccines.' This statement underscores the important role that Belgian scientists and companies play in global healthcare.
The vaccine sector in Belgium has grown significantly in recent years. According to Callewaert, the combination of highly educated talent and a strong research culture is the driving force behind this success. Many scientists consciously choose to start their own companies to bring new medical solutions to patients more quickly.
The work of companies like AstriVax is essential for the future. Vaccines save millions of lives worldwide and prevent the spread of dangerous diseases. By investing in new technologies, the Belgian biotech sector is not only trying to combat existing diseases but also to be prepared for future health crises.
The sector will continue to be an important engine for the Belgian economy in the future. With ongoing support for innovation and scientific research, Belgium remains an attractive place for both investors and international talent. The ambition is clear: the country wants to maintain and further expand its leading position in the medical world.